A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma

BACKGROUND/AIMS: The clinical efficacy and safety of a three-drug combination of melphalan, prednisone, and thalidomide were assessed in patients with multiple myeloma who were not candidates for high-dose therapy as a first-line treatment. Because the side effects of thalidomide at a dose of ≥ 100...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hye Jung, Lee, Jae Hoon, Do, Young Rok, Bae, Sung-Hwa, Lee, Jung-Lim, Nam, Seung Hyun, Yoon, Sung-Soo, Bang, Soo-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245388/
https://www.ncbi.nlm.nih.gov/pubmed/22205840
http://dx.doi.org/10.3904/kjim.2011.26.4.403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245388/
https://www.ncbi.nlm.nih.gov/pubmed/22205840
http://dx.doi.org/10.3904/kjim.2011.26.4.403

Ejemplares similares